Osteocalcin gene expression is regulated by wild-type p53

Calcified Tissue International

Volumn 89, Issue 5, 2011, Pages 411-418

  Chen, Hankui ^a   Hays, Emily ^a   Liboon, Jay ^a   Neely, Chris ^a   Kolman, Kevin ^a   Chandar, Nalini ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Gene regulation; Osteoblast differentiation; Osteocalcin; p53

Indexed keywords

PROTEIN P53; SMALL INTERFERING RNA; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA AFFINITY IMMUNOBLOTTING ASSAY; DNA RESPONSIVE ELEMENT; DOWN REGULATION; GENE; GENE ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OSTEOBLAST; OSTEOCALCIN GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN FUNCTION; RAT; TUMOR SUPPRESSOR GENE; UPREGULATION; WILD TYPE;

ANIMALS; BASE SEQUENCE; BONE REMODELING; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; OSTEOCALCIN; PROMOTER REGIONS, GENETIC; RATS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 82755189341     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-011-9533-x     Document Type: Article

References (35)

1. Hopyan S, Gokgoz N, Bell RS, Andrulis IL, Alman BA, Wunder JS (1999) Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumours. J Orthop Res 17:633-638
2. Price PA, Otsuka AA, Poser JW, Kristaponis J, Raman N (1976) Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci USA 73:1447-1451
3. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G (1996) Increased bone formation in osteocalcindeficient mice. Nature 382:448-452 (Pubitemid 26264860)
4. Goldberg D, Polly P, Eisman JA, Morrison NA (1996) Identification of an osteocalcin gene promoter sequence that binds AP1. J Cell Biochem 60:447-457 (Pubitemid 26112058)
5. Tamura M, Noda M (1994) Identification of a DNA sequence involved in osteoblast-specific gene expression via interaction with helix-loop-helix (HLH)-type transcription factors. J Cell Biol 126:773-782 (Pubitemid 24241389)
6. Ducy P, Karsenty G (1995) Two distinct osteoblast-specific cisacting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858-1869
7. Hassan MQ, Javed A, Morasso MI, Karlin J, Montecino M, van Wijnen AJ, Stein GS, Stein JL, Lian JB (2004) Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol Cell Biol 24:9248-9261 (Pubitemid 39313925)
8. Meyer T, Gustafsson JA, Carlstedt-Duke J (1997) Glucocorticoid- dependent transcriptional repression of the osteocalcin gene by competitive binding at the TATA box. DNA Cell Biol 16:919-927 (Pubitemid 27387905)
9. Sneddon WB, Bogado CE, Kiernan MS, Demay MB (1997) DNA sequences downstream from the vitamin D response element of the rat osteocalcin gene are required for ligand-dependent transactivation. Mol Endocrinol 11:210-217 (Pubitemid 27057434)
10. Paredes R, Arriagada G, Cruzat F, Olate J, Van Wijnen A, Lian J, Stein G, Stein J, Montecino M (2004) The Runx2 transcription factor plays a key role in the 1alpha, 25-dihydroxyvitamin D3- dependent upregulation of the rat osteocalcin (OC) gene expression in osteoblastic cells. J Steroid Biochem Mol Biol 89-90:269-271 (Pubitemid 38844293)
11. Sierra J, Villagra A, Paredes R, Cruzat F, Gutierrez S, Javed A, Arriagada G, Olate J, Imschenetzky M, Van Wijnen AJ, Lian JB, Stein GS, Stein JL, Montecino M (2003) Regulation of the bonespecific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol Cell Biol 23:3339-3351 (Pubitemid 36459245)
12. Rodier F, Campisi J, Bhaumik D (2007) Two faces of p53: aging and tumor suppression. Nucleic Acids Res 35:7475-7484
13. Aloni-Grinstein R, Zan-Bar I, Alboum I, Goldfinger N, Rotter V (1993) Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage. Oncogene 8: 3297-3305 (Pubitemid 23342627)
14. Mazzaro G, Bossi G, Coen S, Sacchi A, Soddu S (1999) The role of wild-type p53 in the differentiation of primary hemopoietic and muscle cells. Oncogene 18:5831-5835 (Pubitemid 29507437)
15. Cerone MA, Marchetti A, Bossi G, Blandino G, Sacchi A, Soddu S (2000) p53 is involved in the differentiation but not in the differentiation-associated apoptosis of myoblasts. Cell Death Differ 7:506-508 (Pubitemid 30255720)
16. Molchadsky A, Shats I, Goldfinger N, Pevsner-Fischer M, Olson M, Rinon A, Tzahor E, Lozano G, Zipori D, Sarig R, Rotter V (2008) p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner. PLoS One 3:e3707
17. Chandar N, Campbell P, Novak J, Smith M (1993) Dependence of induction of osteocalcin gene expression on the presence of wild-type p53 in a murine osteosarcoma cell line. Mol Carcinog 8:299-305 (Pubitemid 24033241)
18. Chandar N, Swindle J, Szajkovics A, Kolman K (2005) Relationship of bone morphogenetic protein expression during osteoblast differentiation to wild type p53. J Orthop Res 23: 1345-1353 (Pubitemid 41554667)
19. Schwartz KA, Lanciloti NJ, Moore MK, Campione AL, Chandar N (1999) p53 transactivity during in vitro osteoblast differentiation in a rat osteosarcoma cell line. Mol Carcinog 25:132-138 (Pubitemid 29275026)
20. Chandar N, Donehower L, Lanciloti N (2000) Reduction in p53 gene dosage diminishes differentiation capacity of osteoblasts. Anticancer Res 20:2553-2559 (Pubitemid 30614467)
21. Lengner CJ, Steinman HA, Gagnon J, Smith TW, Henderson JE, Kream BE, Stein GS, Lian JB, Jones SN (2006) Osteoblast differentiation and skeletal development are regulated by Mdm2- p53 signaling. J Cell Biol 172:909-921
22. Wang X, Kua HY, Hu Y, Guo K, Zeng Q, Wu Q, Ng HH, Karsenty G, de Crombrugghe B, Yeh J, Li B (2006) p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J Cell Biol 172: 115-125 (Pubitemid 43042634)
23. Maruyama R, Aoki F, Toyota M, Sasaki Y, Akashi H, Mita H, Suzuki H, Akino K, Ohe-Toyota M, Maruyama Y, Tatsumi H, Imai K, Shinomura Y, Tokino T (2006) Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res 66: 4574-4583
24. Morrison NA, Shine J, Fragonas JC, Verkest V, McMenemy ML, Eisman JA (1989) 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science 246:1158-1161 (Pubitemid 20012774)
25. Liu Y, Asch H, Kulesz-Martin MF (2001) Functional quantification of DNA-binding proteins p53 and estrogen receptor in cells and tumor tissues by DNA affinity immunoblotting. Cancer Res 61:5402-5406 (Pubitemid 32694918)
26. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B (1991) Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1708-1711 (Pubitemid 21917093)
27. el-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B (1992) Definition of a consensus binding site for p53. Nat Genet 1:45-49
28. Chandar N, Billig B, McMaster J, Novak J (1992) Inactivation of p53 gene in human and murine osteosarcoma cells. Br J Cancer 65:208-214
29. Almog N, Rotter V (1997) Involvement of p53 in cell differentiation and development. Biochim Biophys Acta 1333:F1-F27 (Pubitemid 27360922)
30. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Hee Park S, Thompson T, Karsenty G, Bradley A, Donehower LA (2002) p53 mutant mice that display early ageing-associated phenotypes. Nature 415:45-53 (Pubitemid 34062443)
31. Liu H, Li B (2010) p53 control of bone remodeling. J Cell Biochem 111:529-534
32. Kommagani R, Whitlatch A, Leonard MK, Kadakia MP (2010) p73 is essential for vitamin D-mediated osteoblastic differentiation. Cell Death Differ 17:398-407
33. Tataria M, Quarto N, Longaker MT, Sylvester KG (2006) Absence of the p53 tumor suppressor gene promotes osteogenesis in mesenchymal stem cells. J Pediatr Surg 41:624-632
34. Montecino M, Stein JL, Stein GS, Lian JB, van Wijnen AJ, Cruzat F, Gutierrez S, Olate J, Marcellini S, Gutierrez JL (2007) Nucleosome organization and targeting of SWI/SNF chromatinremodeling complexes: contributions of the DNA sequence. Biochem Cell Biol 85:419-425 (Pubitemid 47518037)
35. Morimoto I, Sasaki Y, Ishida S, Imai K, Tokino T (2002) Identification of the osteopontin gene as a direct target of TP53. Genes Chromosomes Cancer 33:270-278 (Pubitemid 34130933)